Incannex Healthcare IXHL
NASDAQ IXHL
$3.62 +0.18 (+5.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026)

Incannex Healthcare (IXHL) posted Total Non-Current Liabilities of $2.0 million for Q1 2026, down 73.65% sequentially from $7.5 million in Q1 2025, and down 73.65% YoY from $7.5 million in Q1 2025.

Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Incannex Healthcare has reported Total Non-Current Liabilities for 6 years, with the latest figure at $2.0 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 73.65% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 73.65% YoY) and the FY2023 annual result came in at $616087.0, changed N/A from the prior year.
  • Total Non-Current Liabilities eased to $2.0 million in Q1 2026 per IXHL's latest filing, from $7.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $8.9 million in Q4 2024 and troughed at $181519.0 in Q4 2022.
  • A 5-year average of $3.8 million and a median of $2.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities soared 1821.01% in 2023, then plunged 73.65% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $181519.0 in 2022, then jumped by 1821.01% to $3.5 million in 2023, then soared by 153.94% to $8.9 million in 2024, then dropped by 15.62% to $7.5 million in 2025, then slumped by 73.65% to $2.0 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.0 million, $7.5 million, and $8.9 million for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 334.00 Mn
10 Incannex Healthcare 43.22 Mn 43.22 Mn - 1.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.97 Mn
Mar 31, 2025 7.47 Mn
Dec 31, 2024 8.86 Mn
Dec 31, 2023 3.49 Mn
Jun 30, 2023 616,087.00
Dec 31, 2022 181,519.00
Jun 30, 2020 955,006.00